Cargando…
Influence of CYP2C9 and COX-2 Genetic Polymorphisms on Clinical Efficacy of Non-Steroidal Anti-Inflammatory Drugs in Treatment of Ankylosing Spondylitis
BACKGROUND: The aim of this study was to evaluate the relationships of CYP2C9 and COX-2 genetic polymorphisms with therapeutic efficacy of non-steroidal anti-inflammatory drugs (NSAIDs) in treatment of ankylosing spondylitis (AS). MATERIAL/METHODS: We enrolled 130 AS inpatients and outpatients in th...
Autores principales: | Wang, Yu, Yi, Xiao-Dong, Lu, Hai-Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398431/ https://www.ncbi.nlm.nih.gov/pubmed/28403136 http://dx.doi.org/10.12659/MSM.900271 |
Ejemplares similares
-
Correlations of CYP2C9∗3/CYP2D6∗10/CYP3A5∗3 gene polymorphisms with efficacy of etanercept treatment for patients with ankylosing spondylitis: A case–control study
por: Chen, Yuan-Yuan
Publicado: (2017) -
Non-Steroidal Anti-Inflammatory Drug Etoricoxib Facilitates the Application of Individualized Exercise Programs in Patients with Ankylosing Spondylitis
por: Marcu, Iulia Rahela, et al.
Publicado: (2020) -
Non-steroidal Anti-inflammatory Drugs Are Unlikely to Inhibit Radiographic Progression of Ankylosing Spondylitis: A Systematic Review
por: Zhang, Jing-Ru, et al.
Publicado: (2019) -
Are nonsteroidal anti-inflammatory drugs safe for the kidney in ankylosing spondylitis?
por: Kim, Ji-Won
Publicado: (2023) -
Efficacy research of salazosulfamide in ankylosing spondylitis and NAT1 gene polymorphism
por: Ma, Xiu-Fen, et al.
Publicado: (2017)